NCT02600390View on ClinicalTrials.gov

SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Leg Ulcer
Interventions
BIOLOGICAL

SANGUINATE

A two-hour infusion provided once a week over a 4-week or 6-week period.

Trial Locations (2)

Unknown

General Hospital Plaza de la Salud, Santo Domingo

Centro Hemato-Oncologico, Marbella

Sponsors
All Listed Sponsors
lead

Prolong Pharmaceuticals

INDUSTRY